{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:57:19Z","timestamp":1790675839046,"version":"4.1.0"},"reference-count":48,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K07927"],"award-info":[{"award-number":["22K07927"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K11117"],"award-info":[{"award-number":["25K11117"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"award":["22K07927"],"award-info":[{"award-number":["22K07927"]}],"id":[{"id":"https:\/\/ror.org\/02m7axw05","id-type":"ROR","asserted-by":"publisher"}]},{"award":["25K11117"],"award-info":[{"award-number":["25K11117"]}],"id":[{"id":"https:\/\/ror.org\/02m7axw05","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Sanofi LSD","award":["FY2022"],"award-info":[{"award-number":["FY2022"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Lysosomal acid lipase deficiency (LAL-D, OMIM #309900), caused by mutations of the LIPA gene, is involved in two continuum disease phenotypes: Wolman disease in infants and cholesteryl ester storage disease in adults. Their major phenotypes include steatosis, hepatomegaly, splenomegaly, and elevated liver enzymes. Enzyme replacement therapy has been used for the treatment of LAL-D. In this study, we examined the therapeutic effect of liposomal clodronate in an LAL-D mouse model. When liposomal clodronate was administered intraperitoneally by a single administration at 200 mg\/kg to adult mice, organ cholesterol and triglyceride levels partially decreased. Furthermore, a significant correction of the relative organ weight of the liver and spleen as well as a reduction in splenic lipids were observed when liposomal clodronate was administered at 50 mg\/kg to young mice intraperitoneally by multiple administrations. These results demonstrate that liposomal clodronate might have a therapeutic effect on the LAL-D mouse model.<\/jats:p>","DOI":"10.3390\/ijms27198694","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:10:54Z","timestamp":1790673054000},"page":"8694","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of Clodronate on the Pathogenesis in a Mouse Model of Lysosomal Acid Lipase Deficiency"],"prefix":"10.3390","volume":"27","author":[{"given":"Ryuichi","family":"Mashima","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory Medicine, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9406-4683","authenticated-orcid":false,"given":"Shuji","family":"Takada","sequence":"additional","affiliation":[{"name":"Department of Systems BioMedicine, National Research Institute for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"resources","vocabulary":"credit"}]},{"given":"Kei","family":"Murayama","sequence":"additional","affiliation":[{"name":"Diagnostics and Therapeutics of Intractable Diseases, Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo 113-8421, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-original-draft","vocabulary":"credit"}]},{"given":"Takashi","family":"Hamazaki","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-original-draft","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.molmed.2023.03.001","article-title":"Recent Insights into Lysosomal Acid Lipase Deficiency","volume":"29","author":"Korbelius","year":"2023","journal-title":"Trends Mol. Med."},{"key":"ref_2","unstructured":"Anna, N., and Bukiya, A.M.D. (2022). Lysosomal Acid Lipase: Roles in Rare Deficiency Diseases, Myeloid Cell Biology, Innate Immunity, and Common Neutral Lipid Diseases. Cholesterol: From Biophysics to the Clinic, Academic Press. [1st ed.]."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1111\/liv.15620","article-title":"Lysosomal Acid Lipase Deficiency Manifestations in Children and Adults: Baseline Data from an International Registry","volume":"43","author":"Balwani","year":"2023","journal-title":"Liver Int."},{"key":"ref_4","first-page":"3551","article-title":"Acid Lipase Deficiency: Wolman Disease and Cholesteryl Ester Storage Disease","volume":"Volume III","author":"Scriver","year":"2001","journal-title":"The Metabolic & Molecular Bases of Inherited Diseases"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Mashima, R., and Takada, S. (2022). Lysosomal Acid Lipase Deficiency: Genetics, Screening, and Preclinical Study. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232415549"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jhep.2013.02.014","article-title":"Cholesteryl Ester Storage Disease: Review of the Findings in 135 Reported Patients with an Underdiagnosed Disease","volume":"58","author":"Bernstein","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ymgme.2019.11.004","article-title":"Initial Assessment and Ongoing Monitoring of Lysosomal Acid Lipase Deficiency in Children and Adults: Consensus Recommendations from an International Collaborative Working Group","volume":"129","author":"Kohli","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13023-021-01849-7","article-title":"Enzyme Replacement Therapy and Hematopoietic Stem Cell Transplant: A New Paradigm of Treatment in Wolman Disease","volume":"16","author":"Potter","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41409-023-01918-4","article-title":"Outcome of Haematopoietic Cell Transplantation in Children with Lysosomal Acid Lipase Deficiency: A Study on Behalf of the EBMT Inborn Errors Working Party","volume":"58","author":"Lum","year":"2023","journal-title":"Bone Marrow Transplant."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13023-017-0587-3","article-title":"Survival in Infants Treated with Sebelipase Alfa for Lysosomal Acid Lipase Deficiency: An Open-Label, Multicenter, Dose-Escalation Study","volume":"12","author":"Jones","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ymgme.2022.07.014","article-title":"Therapies for Lysosomal Storage Diseases: Principles, Practice, and Prospects for Refinements Based on Evolving Science","volume":"137","author":"Grabowski","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1373\/clinchem.2016.258459","article-title":"Newborn Screening for Lysosomal Storage Disorders: Quo Vadis?","volume":"62","author":"Peake","year":"2016","journal-title":"Clin. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1373\/clinchem.2017.282251","article-title":"Specific Substrate for the Assay of Lysosomal Acid Lipase","volume":"64","author":"Masi","year":"2018","journal-title":"Clin. Chem."},{"key":"ref_14","first-page":"100913","article-title":"LC-MS\/MS-Based Enzyme Assay for Lysosomal Acid Lipase Using Dried Blood Spots","volume":"33","author":"Ohira","year":"2022","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cca.2021.04.005","article-title":"Large-Scale Screening of Lipase Acid Deficiency in at Risk Population","volume":"519","author":"Tebani","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0022-2275(20)31157-3","article-title":"Lysosomal Acid Lipase-Deficient Mice: Depletion of White and Brown Fat, Severe Hepatosplenomegaly, and Shortened Life Span","volume":"4","author":"Du","year":"2001","journal-title":"J. Lipid Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"9118","DOI":"10.1074\/jbc.RA118.007201","article-title":"Hepatocyte-Specific Deletion of Lysosomal Acid Lipase Leads to Cholesteryl Ester but Not Triglyceride or Retinyl Ester Accumulation","volume":"294","author":"Pajed","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.bbalip.2019.01.007","article-title":"Hepatocyte-Specific Lysosomal Acid Lipase Deficiency Protects Mice from Diet-Induced Obesity but Promotes Hepatic Inflammation","volume":"1864","author":"Leopold","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"100427","DOI":"10.1016\/j.jlr.2023.100427","article-title":"Metabolic Changes and Propensity for Inflammation, Fibrosis, and Cancer in Livers of Mice Lacking Lysosomal Acid Lipase","volume":"64","author":"Liesinger","year":"2023","journal-title":"J. Lipid Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2353\/ajpath.2006.051327","article-title":"Macrophage-Specific Expression of Human Lysosomal Acid Lipase Corrects Inflammation and Pathogenic Phenotypes in Lal\u2212\/\u2212 Mice","volume":"169","author":"Yan","year":"2006","journal-title":"Am. J. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"158730","DOI":"10.1016\/j.bbalip.2020.158730","article-title":"Lysosomal Acid Lipase Is the Major Acid Retinyl Ester Hydrolase in Cultured Human Hepatic Stellate Cells but Not Essential for Retinyl Ester Degradation","volume":"1865","author":"Wagner","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ymgme.2014.04.006","article-title":"Reversal of Advanced Disease in Lysosomal Acid Lipase Deficient Mice: A Model for Lysosomal Acid Lipase Deficiency Disease","volume":"112","author":"Sun","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.omtm.2022.08.001","article-title":"Therapeutic Efficacy of RscAAVrh74.MiniCMV. LIPA Gene Therapy in a Mouse Model of Lysosomal Acid Lipase Deficiency","volume":"26","author":"Lam","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"100133","DOI":"10.1016\/j.jlr.2021.100133","article-title":"Hepatic Lysosomal Acid Lipase Overexpression Worsens Hepatic Inflammation in Mice Fed a Western Diet","volume":"62","author":"Lopresti","year":"2021","journal-title":"J. Lipid Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.cmet.2024.03.011","article-title":"New and Emerging Treatments for Metabolic Dysfunction-Associated Steatohepatitis","volume":"36","author":"Tincopa","year":"2024","journal-title":"Cell Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.17925\/EE.2023.19.1.60","article-title":"Resmetirom: An Orally Administered, Smallmolecule, Liver-Directed, \u03b2-Selective THR Agonist for the Treatment of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis","volume":"19","author":"Karim","year":"2023","journal-title":"TouchREVIEWS Endocrinol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S2468-1253(17)30052-3","article-title":"Wolman\u2019s Disease and Cholesteryl Ester Storage Disorder: The Phenotypic Spectrum of Lysosomal Acid Lipase Deficiency","volume":"2","author":"Pericleous","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_28","first-page":"97","article-title":"Clodronate: New Directions of Use","volume":"12","author":"Frediani","year":"2015","journal-title":"Clin. Cases Miner. Bone Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1081\/LPR-120004780","article-title":"Clodronate Liposomes: Perspectives in Research and Therapeutics","volume":"12","year":"2002","journal-title":"J. Liposome Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2896809","DOI":"10.1155\/2017\/2896809","article-title":"Possible Involvement of Liver Resident Macrophages (Kupffer Cells) in the Pathogenesis of Both Intrahepatic and Extrahepatic Inflammation","volume":"2017","author":"Kakinuma","year":"2017","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1016\/j.ajpath.2017.08.020","article-title":"Macrophage Infiltration Is a Causative Factor for Ligamentum Flavum Hypertrophy through the Activation of Collagen Production in Fibroblasts","volume":"187","author":"Saito","year":"2017","journal-title":"Am. J. Pathol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.29421","article-title":"Oncostatin M Causes Liver Fibrosis by Regulating Cooperation between Hepatic Stellate Cells and Macrophages in Mice","volume":"67","author":"Matsuda","year":"2018","journal-title":"Hepatology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1208\/s12248-013-9501-7","article-title":"Intraperitoneal Injection of Clodronate Liposomes Eliminates Visceral Adipose Macrophages and Blocks High-Fat Diet-Induced Weight Gain and Development of Insulin Resistance","volume":"15","author":"Bu","year":"2013","journal-title":"AAPS J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1096\/fj.11-189472","article-title":"Kupffer Cell Depletion Prevents but Has No Therapeutic Effect on Metabolic and Inflammatory Changes Induced by a High-Fat Diet","volume":"25","author":"Lanthier","year":"2011","journal-title":"FASEB J."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Mashima, R., Takada, S., Miyamoto, Y., Murayama, K., and Hamazaki, T. (2026). A Novel Mouse Model of Cholesteryl Ester Storage Disorder with Lipa Exon 8 Splicing Junction Mutation. Sci. Rep.","DOI":"10.1038\/s41598-026-63288-3"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"101737","DOI":"10.1016\/j.molmet.2023.101737","article-title":"Impact of (Intestinal) LAL Deficiency on Lipid Metabolism and Macrophage Infiltration","volume":"73","author":"Bianco","year":"2023","journal-title":"Mol. Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nri1733","article-title":"Monocyte and Macrophage Heterogeneity","volume":"5","author":"Gordon","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","article-title":"Diversity, Mechanisms, and Significance of Macrophage Plasticity","volume":"15","author":"Locati","year":"2020","journal-title":"Annu. Rev. Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1158\/1535-7163.MCT-19-0885","article-title":"Type I IFN, Ly6C+ Cells, and Phagocytes Support Suppression of Peritoneal Carcinomatosis Elicited by a TLR and CLR Agonist Combination","volume":"19","author":"Dyevoich","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2007.04.019","article-title":"Toll-like Receptor-4 Signaling and Kupffer Cells Play Pivotal Roles in the Pathogenesis of Non-Alcoholic Steatohepatitis","volume":"47","author":"Rivera","year":"2007","journal-title":"J. Hepatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/path.5275","article-title":"Bone Marrow-Derived Macrophage Contributes to Fibrosing Steatohepatitis through Activating Hepatic Stellate Cells","volume":"248","author":"Han","year":"2019","journal-title":"J. Pathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"G107","DOI":"10.1152\/ajpgi.00391.2009","article-title":"Kupffer Cell Activation Is a Causal Factor for Hepatic Insulin Resistance","volume":"298","author":"Lanthier","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2165\/00003495-199447060-00007","article-title":"Clodronate. A Review of Its Pharmacological Properties and Therapeutic Efficacy in Resorptive Bone Disease","volume":"47","author":"Plosker","year":"1994","journal-title":"Drugs"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.etap.2016.01.015","article-title":"Bisphosphonates: Pharmacokinetics, Bioavailability, Mechanisms of Action, Clinical Applications in Children, and Effects on Tooth Development","volume":"42","author":"Soares","year":"2016","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1182\/blood-2017-01-764316","article-title":"An Fc-Engineered CD19 Antibody Eradicates MRD in Patient-Derived MLL-Rearranged Acute Lymphoblastic Leukemia Xenografts","volume":"130","author":"Schewe","year":"2017","journal-title":"Blood"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1167\/iovs.05-1427","article-title":"Macrophages Are Vital in Spontaneous Intraocular Tumor Eradication","volume":"47","author":"Boonman","year":"2006","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_47","first-page":"101021","article-title":"Enhanced Osteoblastic Differentiation of Parietal Bone in a Novel Murine Model of Mucopolysaccharidosis Type II","volume":"37","author":"Yamazaki","year":"2023","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Kuentzel, K.B., Bradi\u0107, I., Akhmetshina, A., Korbelius, M., Rainer, S., Kolb, D., Gauster, M., Vuji\u0107, N., and Kratky, D. (2021). Defective Lysosomal Lipolysis Causes Prenatal Lipid Accumulation and Exacerbates Immediately after Birth. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221910416"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8694\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:13:42Z","timestamp":1790673222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":48,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["ijms27198694"],"URL":"https:\/\/doi.org\/10.3390\/ijms27198694","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]}}}